Genkyotex Meets Both Primary and Secondary Interim Efficacy Endpoints in Phase 2 Trial of GKT831 in Primary Biliary Cholangitis Read more
MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013 Read more
BMS and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors Read more
Innovent Receives an Approval from FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188 Read more
Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic Read more
Sarepta Announces Clinical Hold Lifted for its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy Program Read more
Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint Read more
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke Read more